Fundai

Zist Arvand Pharmed Company (DARVAND) monthly reports

The company's monthly activity report on Codal: production and sales, raw materials, energy and foreign currency

Ticker
DARVAND
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Sales amount, 1-month periods
ItemUnitTo 1405/06/31To 1405/05/31To 1405/04/31To 1405/03/31To 1405/02/31To 1405/01/31
Tabletmillion rials5,304,0723,659,1553,976,9154,914,9825,207,8322,694,041
Capsulemillion rials693,143449,470535,270556,466392,375213,243
Softgelmillion rials723,743358,686513,129491,238444,605152,404
Vialmillion rials61,37461,109115,879229,741174,77471,653
Service provisionmillion rials15,6738229,96622,6028,5250
Discountsmillion rials-1,125,524-615,022-1,008,303-1,142,108-1,047,619-536,738
Total domestic salesmillion rials6,782,3324,528,4205,141,1936,192,4276,219,5863,131,341
Total export salesmillion rials0023,833---
Total service revenuemillion rials15,6738229,96622,6028,5250
Totalmillion rials5,672,4813,914,2204,166,6895,072,9215,180,4922,594,603

Reporting periods

18 periods are on file for this report, from the period ending 1404/01/31 to the period ending 1405/06/31.